Johnson & Johnson lowers its FY23 earnings outlook due to the previously announced acquisition of Laminar; will reduce FY24 earnings by $0.15 (154.66 +2.54)
- Co noted that as a result of its previously announced acquisition of Laminar, it will adjust its expected adjusted EPS for FY23, reducing it by $0.17.
- Co issues lowered guidance for FY23 (Dec), sees EPS of $9.90-9.96 (down from $10.07-10.13), excluding non-recurring items, vs. $10.09 FactSet Consensus.
- Additionally, the asset acquisition is expected to have an approximate negative $0.15 EPS impact in fiscal year 2024.